Site Feasibility & Study Start-Up

Start-Up Dashboards & Governance: Building a Control System for Fast, Defensible Activations (2025)

Posted on By digi

Start-Up Dashboards & Governance: Building a Control System for Fast, Defensible Activations (2025) Engineering Start-Up Dashboards and Governance That Turn Dates into Defensible Decisions Purpose, Principles, and the Compliance Frame Start-up dashboards and governance exist for one reason: to move a study from protocol final to first-patient-in (FPI) quickly, safely, and transparently—while leaving an auditable…

Read More “Start-Up Dashboards & Governance: Building a Control System for Fast, Defensible Activations (2025)” »

Site Feasibility & Study Start-Up, Start-Up Dashboards & Governance

Greenlight Checklists & Go/No-Go: A Regulator-Ready Framework for Fast, Defensible Activations (2025)

Posted on By digi

Greenlight Checklists & Go/No-Go: A Regulator-Ready Framework for Fast, Defensible Activations (2025) Greenlight Checklists and Go/No-Go Decisions—From Readiness Evidence to Safe First-Patient-In Purpose, Principles, and the Global Frame for Greenlight Decisions Greenlight is not a date—it is a documented threshold of evidence that a site can protect participants and preserve the integrity of critical endpoints…

Read More “Greenlight Checklists & Go/No-Go: A Regulator-Ready Framework for Fast, Defensible Activations (2025)” »

Greenlight Checklists & Go/No-Go, Site Feasibility & Study Start-Up

Country Depots & Investigational Product Readiness: A Regulator-Ready Playbook for Cold Chain, Compliance, and Speed (2025)

Posted on By digi

Country Depots & Investigational Product Readiness: A Regulator-Ready Playbook for Cold Chain, Compliance, and Speed (2025) Engineering Country Depots and IP Readiness That Withstand Inspection Purpose, Principles, and the Global Compliance Frame Country depots and investigational product (IP) readiness sit on the true critical path to first-patient-in (FPI). They transform protocol intent into safe, traceable…

Read More “Country Depots & Investigational Product Readiness: A Regulator-Ready Playbook for Cold Chain, Compliance, and Speed (2025)” »

Country Depots & IP Readiness, Site Feasibility & Study Start-Up

Readiness Audits: A Regulator-Ready Method for Confident Study Activation (2025)

Posted on By digi

Readiness Audits: A Regulator-Ready Method for Confident Study Activation (2025) Engineering Readiness Audits That Turn Evidence into Safe Activation Purpose, Principles, and the Global Frame Readiness audits are structured, pre-activation examinations that verify whether sites, vendors, and the sponsor’s start-up system can protect participants and preserve endpoint integrity on day one. Unlike routine monitoring or…

Read More “Readiness Audits: A Regulator-Ready Method for Confident Study Activation (2025)” »

Readiness Audits, Site Feasibility & Study Start-Up

Aligning Country & Site Feasibility Assessments With Patient Recruitment, Site Selection and Risk Plans

Posted on By digi

Aligning Country & Site Feasibility Assessments With Patient Recruitment, Site Selection and Risk Plans Aligning Country & Site Feasibility Assessments With Patient Recruitment, Site Selection and Risk Plans In the realm of clinical trials, particularly in sdr clinical trials, effective planning and execution are crucial for both regulatory compliance and the success of the study….

Read More “Aligning Country & Site Feasibility Assessments With Patient Recruitment, Site Selection and Risk Plans” »

Country & Site Feasibility Assessments

Common Pitfalls in Country & Site Feasibility Assessments—and How to Avoid Costly Delays

Posted on By digi

Common Pitfalls in Country & Site Feasibility Assessments—and How to Avoid Costly Delays Common Pitfalls in Country & Site Feasibility Assessments—and How to Avoid Costly Delays Understanding Country and Site Feasibility Assessments Country and site feasibility assessments are critical steps in the clinical trial process, particularly when determining the most suitable locations for a specific…

Read More “Common Pitfalls in Country & Site Feasibility Assessments—and How to Avoid Costly Delays” »

Country & Site Feasibility Assessments

Country & Site Feasibility Assessments in Practice: Step-by-Step Guide for Sponsors and CROs

Posted on By digi

Country & Site Feasibility Assessments in Practice: Step-by-Step Guide for Sponsors and CROs Country & Site Feasibility Assessments in Practice: Step-by-Step Guide for Sponsors and CROs Conducting clinical trials necessitates a structured approach to feasibility assessments to ensure trials can be effectively executed in chosen locations. For sponsors and Contract Research Organizations (CROs), understanding the…

Read More “Country & Site Feasibility Assessments in Practice: Step-by-Step Guide for Sponsors and CROs” »

Country & Site Feasibility Assessments

How to Design Country & Site Feasibility Assessments That Accelerates Study Start-Up and First-Patient-In

Posted on By digi

How to Design Country & Site Feasibility Assessments That Accelerates Study Start-Up and First-Patient-In How to Design Country & Site Feasibility Assessments That Accelerates Study Start-Up and First-Patient-In In the clinical research landscape, conducting country and site feasibility assessments is crucial to ensuring efficient study start-up and an optimal pathway to first-patient-in (FPI). This detailed…

Read More “How to Design Country & Site Feasibility Assessments That Accelerates Study Start-Up and First-Patient-In” »

Country & Site Feasibility Assessments

Country & Site Feasibility Assessments: High-Performance Playbook for US, UK and EU Clinical Trials

Posted on By digi

Country & Site Feasibility Assessments: High-Performance Playbook for US, UK and EU Clinical Trials Country & Site Feasibility Assessments: High-Performance Playbook for US, UK and EU Clinical Trials Conducting clinical trials in a manner that maximizes efficiency and compliance requires thorough planning and assessment of site feasibility. With regulatory authorities including the FDA, EMA, and…

Read More “Country & Site Feasibility Assessments: High-Performance Playbook for US, UK and EU Clinical Trials” »

Country & Site Feasibility Assessments

Integrating Country & Site Feasibility Assessments With Contracts, Budgets and FMV Processes

Posted on By digi

Integrating Country & Site Feasibility Assessments With Contracts, Budgets and FMV Processes Integrating Country & Site Feasibility Assessments With Contracts, Budgets and FMV Processes In the context of clinical research management, the integration of country and site feasibility assessments with contracts, budgets, and Fair Market Value (FMV) processes is critical for ensuring the successful initiation…

Read More “Integrating Country & Site Feasibility Assessments With Contracts, Budgets and FMV Processes” »

Country & Site Feasibility Assessments